My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Xtant Medical Holdings, Inc. Common Stock (NY:XTNT)

0.5845 +0.0012 (+0.21%)

Official Closing Price Updated: 8:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Xtant Medical Holdings, Inc. Common Stock

< Previous 1 2 3 Next >

Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance

May 15, 2024

Via ACCESSWIRE

Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024

May 08, 2024

Via ACCESSWIRE

XTNT Stock Earnings: Xtant Medical Hldgs Misses EPS, Beats Revenue for Q4 2023 ↗

April 01, 2024

XTNT stock results show that Xtant Medical Hldgs missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

Earnings Outlook For Xtant Medical Hldgs ↗

November 08, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 01, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 31, 2023

Via Benzinga

Xtant Medical Raises $15M Via Equity Offering ↗

July 03, 2023

Xtant Medical Holdings, Inc. (AMEX: XTNT) entered into a securities purchase agreement with accredited investors to sell shares of its common stock in a

Via Benzinga

Earnings Scheduled For November 9, 2023 ↗

November 09, 2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 04, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 03, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 03, 2023

Via Benzinga

Surgalign Files For Bankruptcy, Agrees To Sell Global Hardware & Biologics Business ↗

June 20, 2023

Medtech Firm Surgalign Holdings Inc (NASDAQ: SRGA) has entered into an asset purchase agreement to sell its U.S. hardware and biomaterials assets and the equity interests in non-Debtor entities related...

Via Benzinga

Earnings Scheduled For May 4, 2023 ↗

May 04, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 26, 2023 ↗

April 26, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 16, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 15, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 07, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 07, 2023

Via Benzinga

Why Quoin Pharmaceuticals Shares Jumped By More Than 44%; Here Are 57 Biggest Movers From Yesterday ↗

October 19, 2022

Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares jumped 170.1% to close at $0.1194 on Tuesday after gaining 4% on Monday.

Via Benzinga

Why Akouos Shares Are Trading Sharply Higher? Here Are 36 Stocks Moving In Tuesday's Mid-Day Session ↗

October 18, 2022

Gainers

Via Benzinga

Earnings Scheduled For November 3, 2022 ↗

November 03, 2022

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.

Via Benzinga

Why Lululemon Athletica Is Trading Higher By 11%, Here Are 36 Stocks Moving In Friday's Mid-Day Session ↗

September 02, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

August 22, 2022

On Monday, 195 stocks hit new 52-week lows.

Via Benzinga

Earnings Scheduled For May 5, 2022 ↗

May 05, 2022

Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

May 13, 2022

On Friday, 153 companies set new 52-week lows.

Via Benzinga

A Look Into Healthcare Sector Value Stocks ↗

February 28, 2022

What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples...

Via Benzinga

The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares ↗

November 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus J&J to Separate Its Consumer Health Business Into a New Publicly Traded...

Via Benzinga

Earnings Scheduled For March 8, 2022 ↗

March 08, 2022

Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •...

Via Benzinga

Stocks Hitting New 52-Week Lows Today ↗

January 03, 2022

On Monday morning, 60 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows And Highs: Ginkgo Bioworks Holdings (NYSE:DNA) was...

Via Benzinga

Earnings Scheduled For November 12, 2021 ↗

November 12, 2021

Companies Reporting Before The Bell • Zevia (NYSE:ZVIA) is estimated to report quarterly loss at $0.43 per share on revenue of $34.40 million. • Natura &Co...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.